John Yu
Chief Executive Officer at Kairos Pharma Ltd.
John Yu active positions
| Companies | Position | Start | End |
|---|---|---|---|
Kairos Pharma Ltd.
 Kairos Pharma Ltd. Pharmaceuticals: MajorHealth Technology Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA. | Chief Executive Officer | 2013-06-16 | - |
| Chairman | 2013-06-16 | - | |
| Founder | 2013-06-16 | - | |
Cedars-Sinai Medical Center
 Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Cedars-Sinai Medical Center operates a hospital that provides healthcare services. It specializes in cancer, endocrinology, gynecology, neurology, orthopedics, and respiratory disorders. The company was founded in 1902 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | 1997-12-31 | - |
Career history of John Yu
Former positions of John Yu
| Companies | Position | Start | End |
|---|---|---|---|
| EOM PHARMACEUTICALS HOLDINGS, INC. | Director/Board Member | 2015-09-30 | - |
| Chairman | 2007-01-22 | 2015-09-30 | |
| Chief Tech/Sci/R&D Officer | 2006-10-31 | 2015-09-30 | |
| Founder | 2006-10-31 | - | |
| President | 2006-10-31 | 2012-12-02 | |
| Corporate Secretary | 1987-03-19 | - |
Training of John Yu
| Harvard University | Graduate Degree |
| Stanford University | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Statistics
International
| United States | 7 |
Operational
| Chairman | 2 |
| Founder | 2 |
| Director/Board Member | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ. | Health Technology |
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Cedars-Sinai Medical Center operates a hospital that provides healthcare services. It specializes in cancer, endocrinology, gynecology, neurology, orthopedics, and respiratory disorders. The company was founded in 1902 and is headquartered in Los Angeles, CA. | Health Services |
Kairos Pharma Ltd.
Kairos Pharma Ltd. Pharmaceuticals: MajorHealth Technology Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA. | Health Technology |
- Stock Market
- Insiders
- John Yu
- Experience
